Mérieux Equity Partners, France (MxEP) has agreed to invest EUR 40 million into Swixx Biopharma, Switzerland (Swixx), taking a minority position. SIX listed HBM Healthcare Investments who had invested in Swixx in 2017, will co-invest alongside
Tags :Baker McKenzie
Numab Therapeutics, a clinical stage biopharmaceutical company developing next-generation multispecific antibody-based immunotherapies for cancer and inflammation, successfully closes CHF 100 million (approximately USD 110 million) in Series C financing Round. The financing was co-led by new investors
Baker McKenzie advised Swisscanto Invest in the acquisition, on behalf of the Swisscanto Investment Foundation, of a major apartment building complex with 100 apartments in Meyrin near Geneva for CHF 61 million. While the residential leases are
Baker McKenzie has acted as legal adviser to UBS Group and UBS in the agreement to sell its remaining minority stake (48.8%) in Clearstream Fund Centre (CFC) to Deutsche Börse for approximately CHF 390 million.
Baker McKenzie acted as lead counsel to Viasat, the communications company, on the acquisition of Euro Broadband Infrastructure Sàri (EBI), the wholesale broadband services business created as part of Viasat’s former partnering arrangement
Baker McKenzie advised South Pole Holding on the purchase of 100% of the shares in CO2Logic. CO2Logic SA is active in the areas of trading carbon certificates and providing consultancy services to help its
Baker McKenzie advised Fundamenta Real Estate in its public rights offering dedicated to existing shareholders exercising their subscription rights and two shareholders who entered into firm underwriting agreements with the company. The new 5,010,472 registered shares
Baker McKenzie acted as legal advisor to Implantica in its primary issuance of shares, represented by Swedish Depository Receipts (“SDRs”), of SEK 600 million at a subscription price of SEK 122.20 per SDR. The subscription price was
Baker McKenzie has advised Schaffner, a global operator in solutions that ensure the efficient and reliable operation of power electronic systems by shaping electrical power, on the sale of its Power Magnetics Division to Swedish
Nice & Green, an independent Switzerland-based provider of innovative alternative financing solutions for small and mid-sized listed companies, announced a minority growth investment by Artemis Group, owned by Swiss entrepreneur Michael Pieper. The capital raised
